Dr. Reddy's Laboratories Reports Strong Q3 FY24-25 Results with Record Sales and Profitability
Dr. Reddy's Laboratories has announced its financial results for the third quarter of FY24-25, showcasing significant improvements across key performance indicators. The company achieved record net sales, operating profit, and profit before tax, alongside a notable increase in earnings per share, highlighting a strong operational and profitability trend.
Dr. Reddy's Laboratories has released its financial results for the third quarter of FY24-25, revealing noteworthy developments in its performance metrics. The company reported net sales of Rs 8,381.20 crore, achieving the highest level recorded in the last five quarters. This uptick in sales is complemented by an operating profit (PBDIT) of Rs 2,273.00 crore, which also marks a peak for the same period, suggesting a favorable trend in operational efficiency.The profit before tax (PBT) reached Rs 1,724.10 crore, again the highest in the past five quarters, indicating a robust performance in terms of profitability. Furthermore, the profit after tax (PAT) was reported at Rs 1,413.70 crore, reflecting a positive trajectory in the company's earnings. The earnings per share (EPS) stood at Rs 16.95, the highest in the last five quarters, signaling enhanced profitability for shareholders.
In light of these results, there have been evaluation changes regarding Dr. Reddy's Laboratories, reflecting the company's solid financial metrics in its latest quarterly report.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
